Nexalin Technology (NXL) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

NXL Nexalin Technology

Watchlist

1.5401
+0.2201+16.67%

Trading Apr 18 10:11 ET

11.45MMarket Cap-2444P/E (TTM)

Intraday

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Lexaria Bioscience, Biosig Technologies, BIMI Holdings Among Healthcare Movers
Seeking AlphaApr 17 10:00 ET
JAGX, BSGM and SXTC Among Mid-day Movers
Seeking AlphaApr 16 12:40 ET
Nexalin Technology Files to Offer Common Stock Worth $5.65M
Seeking AlphaApr 16 11:30 ET
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics Among Healthcare Movers
Seeking AlphaApr 16 10:00 ET
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers
Seeking AlphaApr 9 10:00 ET
Express News | Nexalin Technology Accelerates HALO Clarity Manufacturing; Expects To Produce ~500 Units In Q3 2024
Moomoo 24/7Apr 9 08:45 ET

Comments

103115790

Yesterday 00:00

$Nexalin Technology(NXL.US)$ why kept circuit breaker?

Sean Parker

Apr 4 14:06

Nexalin Technology Awarded Key Patent Related To Gen-3 HALO Clarity

$Nexalin Technology(NXL.US)$

richisrich

Apr 4 12:08

🚀

$Nexalin Technology(NXL.US)$

Jaguar8

Apr 4 12:01

$Nexalin Technology(NXL.US)$
NEWS
Nexalin Technology, Inc. receives a new method of use patent for their non-invasive deep brain stimulation device, enabling treatment for anxiety, depression, and insomnia from the comfort of patients' homes. The patent covers the technology utilized in their Gen-3 HALO Clarity™ system, extending through 2040. CEO Mark White highlights the significance of the patent in enhancing the company's strategy and clinical data supporting the device's benefits. The Gen-3...